“Bimekizumab Long-Term On-Treatment Remission and Associated Sustained Improvements in Quality of Life in Moderate to Severe Plaque Psoriasis Across Five Phase 3 3b Trials”. SKIN The Journal of Cutaneous Medicine 10, no. 3 (May 11, 2026): s772. Accessed June 10, 2026. https://skin.dermsquared.com/skin/article/view/4229.